References
- Scortichini M, Schneider Dos Santos R, De’ Donato F, et al. Excess mortality during the COVID-19 outbreak in Italy: a two-stage interrupted time-series analysis. Int J Epidemiol. 2021;49:1909–1917.
- Parohan M, Yaghoubi S, A S, et al. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Aging Male. 2020;23:1416–1424.
- Li J, Huang DQ, Zou B, et al. Epidemiology of COVID-19: a systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. J Med Virol. 2021;93:1449–1458.
- Italian Ministry of Health. Ad interim recommendations on target groups for anti-SARS-CoV-2/COVID-19 vaccination. [Cited 2021 Aug 20]. Available from: https://www.trovanorme.salute.gov.it/norme/renderPdf.spring?seriegu=SG&datagu=24/03/2021&redaz=21A01802&artp=1&art=1&subart=1&subart1=10&vers=1&prog=002
- Steyerberg EW, Moons KGM, van der Windt DA, et al. Prognosis research strategy (PROGRESS) 3: prognostic model research. PLoS Med. 2013;10:e1001381.
- Wynants L, Van Calster B, Collins GS, et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ. Update in: BMJ. 2021;372:n236. Erratum in: BMJ. 2020;369:m2204. 2020;369:m1328.
- Ramspek CL, Jager KJ, Dekker FW, et al. External validation of prognostic models: what, why, how, when and where? Clin Kidney J. 2020;14:49–58.
- Pasquariello P, Stranges S. Excess mortality from COVID-19: a commentary on the Italian experience. Int J Public Health. 2020;65:529–531.
- Cecconi M, Piovani D, Brunetta E, et al. Early predictors of clinical deterioration in a cohort of 239 patients hospitalized for Covid-19 infection in Lombardy, Italy. J Clin Med. 2020;9:1548
- Borghesi A, Maroldi R. COVID-19 outbreak in Italy: experimental chest X-ray scoring system for quantifying and monitoring disease progression. Radiol Med. 2020;125:509–513.
- Bartoletti M, Giannella M, Scudeller L, et al. Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study). Clin Microbiol Infect. 2020;26:1545–1553.
- Collins GS, Reitsma JB, Altman DG, et al. Transparent Reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med. 2015;162:55–63.
- Lapi F, Bianchini E, Michieli R, et al. Assessing risk of osteoporotic fractures in primary care: development and validation of the FRA-HS algorithm. Calcif Tissue Int. 2017;100:1–13.
- Dentali F, Fontanella A, Cohen AT, et al. Derivation and validation of a prediction model for venous thromboembolism in primary care. Thromb Haemost. 2020;120:692–701.
- Lapi F, Marconi E, Simonetti M, et al. Adjuvanted versus nonadjuvanted influenza vaccines and risk of hospitalizations for pneumonia and cerebro/cardiovascular events in the elderly. Expert Rev Vaccines. 2019;18:663–670.
- Royston P, Altman DG. External validation of a cox prognostic model: principles and methods. BMC Med Res Methodol. 2013;13:13.
- Huang Y, Li W, Macheret F, et al. A tutorial on calibration measurements and calibration models for clinical prediction models. J Am Med Inform Assoc. 2020;27:621–633.
- Royston P. Tools for checking calibration of a cox model in external validation: approach based on individual event probabilities. Stata J. 2014;14:738–755.
- Smith GCS, Seaman SR, Wood AM, et al. Correcting for optimistic prediction in small data sets. Am J Epidemiol. 2014;180:318–324.
- Salim A, Delcoigne B, Villaflores K, et al. Comparisons of risk prediction methods using nested case-control data. Stat Med. 2017;36:455–465.
- Italian Civil Defense. COVID-19 open data. [Cited 2021 Aug 20]. Available from: https://github.com/pcm-dpc/COVID-19
- Rimmer A. Covid-19: gPs have “stepped up” in time of national crisis, says profession’s leader. BMJ. 2020;371:m4671.
- Klein JO, Myers MG. Vaccine shortages: why they occur and what needs to be done to strengthen vaccine supply. Pediatrics. 2006;117:2269–2275.
- Callaway E. COVID vaccine boosters: the most important questions. Nature. 2021;596:178–180.
- Food and Drug Administration (FDA). Coronavirus (COVID-19) update: FDA authorizes additional vaccine dose for certain immunocompromised individuals. [Cited 2021 Aug 20]. Available from: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-vaccine-dose-certain-immunocompromised
- Centers for Disease Control and Prevention (CDC). COVID-19 vaccines for moderately to severely immunocompromised people. [Cited 2021 Aug 20]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html
- Mahase E. Covid-19: booster vaccine to be rolled out in autumn as UK secures 60m more Pfizer doses. BMJ. 2021;373(n1116).
- Kamar N, Abravanel F, Marion O, et al. Three doses of an mRNA Covid-19 Vaccine in solid-organ transplant recipients. N Engl J Med. 2021;385:661–662.
- Hall VG, Ferreira VH, Ku T, et al. Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients. N Engl J Med. 2021;385:1244–1246.
- Ducloux D, Colladant M, Chabannes M, et al. Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis. Kidney Int. 2021;100:702–704.
- World Health Organization (WHO). Interim statement on COVID-19 vaccine booster doses. [Cited 2021 Aug 20]. Available from: https://www.who.int/news/item/10-08-2021-interim-statement-on-covid-19-vaccine-booster-doses
- Murray CJL, Piot P. The potential future of the Covid-19 pandemic: will sars-Cov-2 become a recurrent seasonal infection?. JAMA. 2021;325:1249–1250.
- Domnich A, Cambiaggi M, Vasco A, et al. Attitudes and beliefs on influenza vaccination during the Covid-19 pandemic: results from a representative Italian survey. Vaccines (Basel). 2020;8:1–20.
- Gerussi V, Peghin M, Palese A, et al. Vaccine hesitancy among italian patients recovered from Covid-19 infection towards influenza and sars-Cov-2 Vaccination. Vaccines (Basel). 2021;9:1–10.
- DeCaprio D, Gartner J, McCall CJ, et al. Building a COVID-19 Vulnerability Index. Journal of Medical Artificial Intelligence. 2020;3:. Available from: https://jmai.amegroups.com/article/view/5930
- Reps JM, Kim C, Williams RD, et al. Implementation of the COVID-19 vulnerability index across an international network of health care data sets: collaborative external validation study. JMIR Med Inf. 2021;9:e21547.
- Steyerberg EW, Harrell FE. Prediction models need appropriate internal, internal-external, and external validation. J Clin Epidemiol. 2016;69:245–247.
- Cricelli C, Mazzaglia G, Samani F, et al. Prevalence estimates for chronic diseases in Italy: exploring the differences between self‐report and primary care databases. J Public Health (Bangkok). 2003;25:254–257.
- Gini R, Francesconi P, Mazzaglia G, et al. Chronic disease prevalence from Italian administrative databases in the VALORE project: a validation through comparison of population estimates with general practice databases and national survey. BMC Public Health. 2013;13:1–11.
- Gini R, Schuemie MJ, Francesconi P, et al. Can Italian healthcare administrative databases be used to compare regions with respect to compliance with standards of care for chronic diseases?. PLoS One. 2014;9(5):e95419.
- Campbell F, Archer B, Laurenson-Schafer H, et al. Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021. Euro Surveill. 2021;26(24):1–6.